Measurable or assessable disease in lung cancer trials: does it matter?

Jett, J R

Measurable or assessable disease in lung cancer trials: does it matter? [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 1994 - 2677-81 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.1994.12.12.2677 doi


Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials, Phase III as Topic--methods
Confidence Intervals
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Multivariate Analysis
Neoplasm Staging
Prospective Studies
Survival Rate
Treatment Outcome